{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:23:01Z","timestamp":1791559381264,"version":"4.3.4"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Neuroleptic malignant syndrome (NMS) is an uncommon, but potentially life- threatening complication of antipsychotic therapy, primarily resulting from central dopaminergic blockade. NMS is a clinical diagnosis and occurs rarely in patients receiving atypical antipsychotics agents. Gastrointestinal manifestations, including severe hypomotility and paralytic ileus, are recognized adverse effects of antipsychotic medications. However, paralytic ileus preceding the characteristic neuromuscular and autonomic features of NMS is exceptionally rare and underrecognized as an early manifestation of the syndrome. We report the case of a 49-year-old man who presented with progressive abdominal distension secondary to intestinal pseudo-obstruction as an early manifestation of NMS. This atypical and underreported presentation highlights the importance of maintaining a high index of suspicion for NMS in patients receiving antipsychotic therapy who develop unexplained gastrointestinal dysmotility. Prompt recognition, immediate discontinuation of the offending antipsychotic agent, and early initiation of treatment with dantrolene and bromocriptine resulted in a favorable clinical outcome.<\/jats:p>","DOI":"10.3389\/fmed.2026.1911402","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:21:35Z","timestamp":1788412895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Paralytic ileus as an early manifestation of evolving neuroleptic malignant syndrome in a patient receiving anti-psychotics"],"prefix":"10.3389","volume":"13","author":[{"given":"Balakrishnan","family":"Arivalagan","sequence":"first","affiliation":[{"name":"BronxCare Health System","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragathi","family":"Munnangi","sequence":"additional","affiliation":[{"name":"BronxCare Health System","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashkumar Girdharlal","family":"Kamani","sequence":"additional","affiliation":[{"name":"BronxCare Health System","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Guglani","sequence":"additional","affiliation":[{"name":"Ross University School of Medicine","place":["Bridgetown, Barbados"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Barrera","sequence":"additional","affiliation":[{"name":"BronxCare Health System","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Singh","sequence":"additional","affiliation":[{"name":"Ross University School of Medicine","place":["Bridgetown, Barbados"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makker","family":"Jasbir","sequence":"additional","affiliation":[{"name":"BronxCare Health System","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Patel","sequence":"additional","affiliation":[{"name":"BronxCare Health System","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misbahuddin","family":"Khaja","sequence":"additional","affiliation":[{"name":"BronxCare Health System","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson","year":"1985","journal-title":"Am J Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s40263-017-0448-6","article-title":"Clozapine-induced gastrointestinal Hypomotility: a 22-year bi-National Pharmacovigilance Study of serious or fatal slow gut reactions and comparison with international drug safety advice","volume":"31","author":"Every-Palmer","year":"2017","journal-title":"CNS Drugs"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.eurpsy.2010.03.003","article-title":"Second-generation antipsychotics and constipation: a review of the literature","volume":"26","author":"De Hert","year":"2011","journal-title":"Eur Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.bpg.2007.03.001","article-title":"Acute colonic pseudo-obstruction","volume":"21","author":"Saunders","year":"2007","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref5","first-page":"832","article-title":"Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome","volume":"168","author":"Gurrera","year":"2011","journal-title":"Am J Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"Strawn","year":"2007","journal-title":"Am J Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ebiom.2016.02.020","article-title":"Clozapine-treated patients have marked gastrointestinal hypomotility, the probable basis of life-threatening gastrointestinal complications: a cross-sectional study","volume":"5","author":"Every-Palmer","year":"2016","journal-title":"EBioMedicine"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ajp.2017.05.004","article-title":"Neuroleptic malignant syndrome: a neuro-psychiatric emergency: recognition, prevention, and management","volume":"29","author":"Velamoor","year":"2017","journal-title":"Asian J Psychiatr"},{"key":"ref10","first-page":"1641","article-title":"Neuroleptic malignant syndrome","volume":"386","author":"Rosenberg","year":"2022","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/hup.470080511","article-title":"Paralytic ileus as a prodromal symptom of the neuroleptic malignant syndrome","volume":"8","author":"Tanaka","year":"1993","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1034\/j.1399-6576.2003.00193.x","article-title":"Neuroleptic malignant syndrome with severe liver failure","volume":"47","author":"Urving","year":"2003","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.4306\/pi.2016.13.6.665","article-title":"A case of ileus in a patient with schizophrenia under paliperidone palmitate treatment","volume":"13","author":"Can","year":"2016","journal-title":"Psychiatry Investig"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.12890\/2016_000368","article-title":"A fatal case of neuroleptic malignant syndrome after paralytic bowel in a patient taking antiparkinson medication","volume":"3","author":"Campa","year":"2016","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1159\/000492460","article-title":"Acute abdomen with ileus: a heralding presentation of neuroleptic malignant syndrome","volume":"12","author":"Chime","year":"2018","journal-title":"Case Rep Gastroenterol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1911402\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:21:36Z","timestamp":1788412896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1911402\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":15,"alternative-id":["10.3389\/fmed.2026.1911402"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1911402","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1911402"}}